Careers
Working at Gavi
Compensation and benefits
Internship programme
Vacancies
Contact
Ethics hotline
RFP
Donate
French
Follow on Google+
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
Follow on Youtube
Follow on Flickr
Follow on Instagram
Suscribe to RSS feed
Home
About Gavi
Learn more about Gavi
Gavi's mission
Gavi's strategy
Value of vaccination
Gavi's partnership model
Gavi's business model
Market shaping
Global health and development
Governing Gavi
Support
What Gavi offers and how it works
How our support works
New and underused vaccines support
Human papillomavirus vaccine
Inactivated polio vaccine
Japanese encephalitis vaccine
Measles vaccine
Measles-rubella vaccine
Meningitis A vaccine
Oral cholera vaccine
Pentavalent vaccine
Pneumococcal vaccine
Rotavirus vaccine
Yellow fever vaccine
Health system strengthening
Immunisation supply chain
Cold Chain Equipment Optimisation Platform
Partners' engagement framework
Making immunisation sustainable
Immunisation services support
Civil society organisation
National coordination forums
Country hub
Afghanistan
Albania
Angola
Armenia
Azerbaijan
Bangladesh
Benin
Bhutan
Bolivia
Bosnia & Herzegovina
Burkina Faso
Burundi
Cambodia
Cameroon
Central African Republic (the)
Chad
China
Comoros
Congo
Congo, DR
Côte d’Ivoire
Cuba
Djibouti
Eritrea
Ethiopia
Gambia
Georgia
Ghana
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
India
Indonesia
Kenya
Kiribati
Korea, DPR
Kyrgyzstan
Lao PDR
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Moldova
Mongolia
Mozambique
Myanmar
Nepal
Nicaragua
Niger
Nigeria
Pakistan
Papua New Guinea
Rwanda
Sao Tome and Principe
Senegal
Sierra Leone
Solomon Islands
Somalia
South Sudan
Sri Lanka
Sudan
Tajikistan
Tanzania, UR
Timor Leste
Togo
Turkmenistan
Uganda
Ukraine
Uzbekistan
Vietnam
Yemen
Zambia
Zimbabwe
Funding & finance
Long-term financial commitments
How Gavi is funded
Key figures: donor contributions & pledges
Donor profiles
Financial reports
Gavi Matching Fund
International Finance Facility for Immunisation
Pneumococcal AMC
INFUSE
About INFUSE
How to get involved
INFUSE community
Calls for innovation
Results & evidence
Measuring & evaluating performance
Measuring our performance
2016–2020 indicators
2011–2015 indicators
Countries approved for support
Disbursements and commitments
Gavi's evaluation studies
Full country evaluations
Gavi support to Bosnia and Herzegovina evaluation
Health system strengthening evaluations 2013-2015
Pneumococcal AMC outcomes and impact evaluation
Technical assistance through the partners' engagement framework evaluation
Gavi Progress Reports
Library & news
Search by topic, country and programme
News
Press releases
Statements
Gavi features
Audio-visual
Board & committee minutes
Gavi documents
Country documents
Evaluations
Financial reports
Guidelines and forms
Policies
Strategy
Supply and procurement
Publications
Events
You are here:
Library
Audio-visual
Audio-visual
Galleries
Galleries
Inky fingers point to healthy future for Malawi's children
Inky fingers point to healthy future for Malawi's children
in page functions
Usually parents are quick to ask children to scrub their inky fingers – but not after a recent life-saving vaccination campaign in Malawi. Close to 8 million children’s fingers were marked with an ink stain to show that they had been immunised against two deadly diseases – measles and rubella.
Gavi/2017/Karel Prinsloo
Alabia Alan proudly holds up her daughter’s inky finger – a sign that she has received the measles-rubella vaccine. She is one of close to 8 million children aged between 9 months and 14 years who were immunised as part of a national vaccination campaign in June.
Gavi/2017/Karel Prinsloo
In total, 11,000 vaccination sites were set up at health facilities and schools across the country. Following the campaign, the government will introduce the vaccine into the national immunisation programme to make sure future generations are protected.
Gavi/2017/Karel Prinsloo
Dorothy Ngwena, aged 44, is one of 22,000 health workers deployed throughout Malawi. The health workers, together with an additional 33,000 community volunteers, took the opportunity to reach millions of children with other health services, including vitamin A supplements and deworming tablets.
Gavi/2017/Karel Prinsloo
Malawi’s health workers played a frontline role in informing parents about the campaign, alongside other social mobilisation tactics. Liana Jere brought her nearly two-year-old daughter Nelia to be immunised after hearing a radio broadcast.
Gavi/2017/Karel Prinsloo
Gavi worked closely with its partners WHO and UNICEF to support Malawi’s immunisation campaign. In addition to Gavi funding, WHO provided technical assistance and training, while UNICEF helped the government with logistics and social mobilisation.
Gavi/2017/Karel Prinsloo
Globally, measles remains one of the leading causes of death among young children globally, despite the availability of a safe and effective vaccine. While rubella is a mild disease, it can have serious consequences if it strikes during pregnancy and causes congenital rubella syndrome.
Learn more
about Gavi’s support for measles-rubella vaccine.
Latest galleries
Inky fingers point to healthy future for Malawi's children
Halting the spread of cholera in Somalia
The women who made modern vaccines work
Close to 1 million Myanmar children to be protected with pneumococcal vaccine
Rebirth of Liberia's health system: a dual celebration
A brighter future in Sierra Leone thanks to the power of vaccines
Fighting pneumonia in Nepal - surveillance, strains and schedules
Red Nose Day 2015
Keeping DR Congo polio-free
Mind the gap: vaccine disparity claiming women’s lives
View all galleries
modal window here